Prognostic value of combined preoperative phase angle and handgrip strength in cardiac surgery.

All-cause mortality Cardiac surgery Coronary artery bypass grafting Handgrip strength Phase angle

Journal

Journal of cardiothoracic surgery
ISSN: 1749-8090
Titre abrégé: J Cardiothorac Surg
Pays: England
ID NLM: 101265113

Informations de publication

Date de publication:
03 Sep 2022
Historique:
received: 07 03 2022
accepted: 20 08 2022
entrez: 3 9 2022
pubmed: 4 9 2022
medline: 8 9 2022
Statut: epublish

Résumé

Phase angle (PA) constitutes a bioelectrical impedance measurement, indicating cell membrane health and integrity, hydration, and nutritional status. Handgrip strength (HS) has been also associated with body composition, nutritional status, inflammation, and functional ability in several chronic diseases. Although their prognostic significance as independent biomarkers has been already investigated regarding the outcomes of a cardiac surgery, our study is the first one to assess the combined predictive value of preoperative PA and HS. HS and PA measurements were performed preoperativelyin 195 patients undergoing cardiac surgery. The association ofthe combination of HS and PAwith all-cause mortality rates was the primary study outcome, while its association with the intensive care unit (ICU) length of stay (LOS) was the secondary one. PA was positively correlated with HS (r = 0.446, p < 0.005) and negatively with EuroSCORE II (r = - 0.306 p < 0.005). The combination of PA < 5.15 and HS < 25.5 was associated with higher one-year all-cause mortality (OR = 9.28; 95% CI 2.50-34.45; p = 0.001) compared to patients with PA > 5.15 and HS > 25.5, respectively. Patients with combined lower values of PA and HS (PA < 5.15 and HS < 30.7) were at higher risk of prolonged ICU LOS (OR = 4.02; 95% CI 1.53-10.56; p = 0.005) compared to those with higher PA-HS (PA > 5.15-HS > 30.7). The combination of PA-HS was also significantly linked with EuroSCORE II. The combination of low preoperative PA and HS values was significantly associated with higher risk of all-cause mortality at 12 months and prolonged ICU LOS; thereby it might serve as a clinically useful prognostic biomarker after cardiac surgery procedures.

Identifiants

pubmed: 36057619
doi: 10.1186/s13019-022-01970-z
pii: 10.1186/s13019-022-01970-z
pmc: PMC9440499
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

227

Informations de copyright

© 2022. The Author(s).

Références

Biomark Med. 2021 Mar;15(4):307-318
pubmed: 33590769
Can J Cardiol. 2021 Nov;37(11):1760-1766
pubmed: 34464690
BMC Cardiovasc Disord. 2019 Nov 27;19(1):266
pubmed: 31775633
Ann Thorac Surg. 2004 Nov;78(5):1528-34
pubmed: 15511424
Clin Nutr. 2021 May;40(5):3182-3190
pubmed: 33581951
Heart Asia. 2018 Apr 4;10(1):e011017
pubmed: 29637928
Eur J Cardiothorac Surg. 2004 Feb;25(2):203-7
pubmed: 14747113
Nutr Clin Pract. 2019 Oct;34(5):760-766
pubmed: 30864228
J Am Heart Assoc. 2018 Sep 4;7(17):e008721
pubmed: 30371163
Am J Clin Nutr. 2000 Aug;72(2):496-501
pubmed: 10919947
Clin Nutr. 2012 Dec;31(6):854-61
pubmed: 22698802
BMC Anesthesiol. 2012 Jan 17;12:1
pubmed: 22251661
Eur J Clin Nutr. 2022 Apr 12;:
pubmed: 35414661
J Card Surg. 2008 Mar-Apr;23(2):99-106
pubmed: 18304122
Eur J Prev Cardiol. 2022 Feb 19;29(1):216-227
pubmed: 34270717
CMAJ. 2010 Mar 23;182(5):429-35
pubmed: 20142372
J Card Surg. 2022 Jan;37(1):88-92
pubmed: 34618985
Clin Nutr. 2016 Dec;35(6):1530-1534
pubmed: 27118274
J Gen Intern Med. 2014 Jan;29(1):147-54
pubmed: 24002625
Clin Nutr. 2011 Apr;30(2):135-42
pubmed: 21035927
Support Care Cancer. 2013 Dec;21(12):3261-70
pubmed: 23872952
Eur J Clin Nutr. 2019 Apr;73(4):495-508
pubmed: 29695763
BMC Health Serv Res. 2016 Jul 29;16:318
pubmed: 27473872

Auteurs

Mairi Panagidi (M)

Department of Cardiothoracic Surgery, AHEPA University Hospitalof Thessaloniki, Thessaloniki, Greece.

Αndreas S Papazoglou (ΑS)

First Department of Cardiology, AHEPA University Hospital of Thessaloniki, Thessaloniki, Greece.

Dimitrios V Moysidis (DV)

First Department of Cardiology, AHEPA University Hospital of Thessaloniki, Thessaloniki, Greece.

Elpiniki Vlachopoulou (E)

Department of Nutritional Sciences, International Hellenic University, Thessaloniki, Greece.

Marios Papadakis (M)

University Witten-Herdecke, Witten, Germany. marios_papadakis@yahoo.gr.

Evangelia Kouidi (E)

Laboratory of Sports Medicine, Department of Physical Education and Sports Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Antonios Galanos (A)

Department of Medicine, National and Kapodistrian University of Athens, Athens, Greece.

Georgios Tagarakis (G)

Department of Cardiothoracic Surgery, AHEPA University Hospitalof Thessaloniki, Thessaloniki, Greece.

Kyriakos Anastasiadis (K)

Department of Cardiothoracic Surgery, AHEPA University Hospitalof Thessaloniki, Thessaloniki, Greece.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH